Shape Memory Medical has filed a notice of an exempt offering of securities to raise $37,832,624.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Shape Memory Medical is raising up to $37,832,624.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Edward Ruppel played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Shape Memory Medical
Shape Memory Medical is dedicated to developing innovative therapeutic solutions for peripheral vascular, cardiovascular, and neurovascular markets. We are the first medical device company to introduce an FDA-cleared medical device utilizing shape memory polymer (SMP) technology to a vascular market.
To learn more about Shape Memory Medical, visit http://www.shapemem.com/
Contact:
Edward Ruppel, Chief Executive Officer
408-649-5175
https://www.linkedin.com/in/tedruppel/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.